Search
An innovative collaboration between basic scientists and clinical researchers has led to a promising new drug for AML.
Memorial Sloan Kettering is sad to note the passing on May 12 of Stephen Sternberg, at the age of 100. Dr. Sternberg spent his entire career at MSK as a surgical pathologist. Widely known as a leader in the field of pathology and highly regarded for his expertise, he was also greatly respected as an editor of major national publications, which garnered him a broad, devoted following around the world.
Moritz Kircher, MD, PhD, has been selected by the directors of the Dana Foundation as a Dana Neuroscience Scholar.
The reason certain patients with follicular lymphoma do worse than others may come down to a missing gene.
Research led by investigators at Memorial Sloan Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib.
Learn about Verdun Perry’s devotion to fund rare cancer research at MSK.
New findings provide details about the hidden organization of the cytoplasm, showing it makes a big difference where in that cellular broth that messenger RNA (mRNA) get translated into proteins. The findings hold promise for increasing or altering the production of proteins in mRNA vaccines and therapies.
A new study in flies reveals a previously unknown type of cooperation at work in muscle cells.
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Meet Roseann Tucci and her daughter Gabriella, both nurses dedicated to caring for patients in the Department of Pediatrics at Memorial Sloan Kettering.